Maksim A. Kopenkin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maksim A. Kopenkin has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Vladimir V. Bazarnyi
Ural State Medical University
14 shared publications - Larisa Georgievna Polushina
Ural State Medical University
11 shared publications - Elena Vladimirovna Kudryavtseva
Ural State Medical University
4 shared publications - E. A. Sementsova
Ural State Medical University
3 shared publications - Oksana V. Koryakina
Ural State Medical University
3 shared publications - Olga P. Kovtun
Ural State Medical University
3 shared publications
Latest Publications
- 11 August 2026
- Published by FSBI Research Institute of Occupational Health RAMS in Russian Journal of Occupational Health and Industrial Ecology
- Vol. 66 (7) , 456-462
Study of the state of the cardiovascular system in laboratory animals after chronic inhalation exposure to lead oxide nanoparticles
Introduction. Current data indicate that lead oxide nanoparticles have a more pronounced toxicity compared to microparticles, organic and inorganic lead salts. Lead intoxication is a significant risk factor for the development of cardiovascular diseases. The features of the cardiotoxic effect of lead oxide nanoparticles require further study.The study aims to evaluate changes in clinical, functional, and metabolic parameters characterizing the state of the cardiovascular system during inhalation exposure to lead oxide nanoparticles for 4 months.Materials and methods. The authors conducted an experiment on female rats divided into two equal groups: the main group (n=10) and the control group (n=10). The experimental group was exposed to lead oxide nanoparticles by inhalation at a concentration of 0.2 mg/m³ for 4 months. An electrocardiogram and blood pressure were recorded. Histological examination and metabolomic analysis of heart tissue were performed. The concentration of coproporphyrin and delta-aminolevulinic acid in urine was determined.Results. The scientists found an increase in pulse pressure (p=0.020), a reduction in the QT interval in the first lead (p=0.027) and the QRS complex in the second (p=0.020). There was an increase in the size of cardiomyocytes (p<0.001). Metabolic analysis of heart tissue revealed an increase in the levels of proline (p=0.019), adenine (p=0.010), methionine sulfoxide (p=0.038), succinyl adenosine (p=0.019), linoleic acid (p=0.010), lysophosphatidylethanolamines 18:0 and 18:1 (p=0.010 and p=0.038, respectively) and lysophosphatidylcholines 18:1 and 18:2 (p=0.038 and p=0.038).Limitations. This work does not take into account possible intersex and interspecific differences.Conclusion. The results of the study showed that exposure to lead oxide nanoparticles causes changes in blood pressure, has a proarrhythmogenic effect, contributes to an increase in the size of cardiomyocytes and the development of oxidative stress.Ethics. The study was approved at a meeting of the Local Ethics Committee of the Yekaterinburg Medical Scientific Center for the Prevention and Health Protection of Industrial Workers of Rospotrebnadzor (Protocol No. 4 dated 07/12/2022).Contributions:Minigalieva I.A. — concept and design of research, writing, editing;Sutunkova M.P. — concept and design of research, editing;Kopenkin M.A. — data collection and processing, text writing, editing;Unesikhina M.C. — data collection and processing, text writing, editing;Petrunina E.M. — data collection and processing;Bazarnyi V.V. — concept and design of research, editing;All co-authors — approving the final version of the article and ensuring the integrity of all parts of the article.Funding. The study had no funding.Conflict of interest. The authors declare no conflict of interest.Received: 07.05.2026 / Accepted: 14.05.2026 / Published: 11.08.2026
- 11 August 2026
- Published by FSBI Research Institute of Occupational Health RAMS in Russian Journal of Occupational Health and Industrial Ecology
- Vol. 66 (7) , 456-462
Study of the state of the cardiovascular system in laboratory animals after chronic inhalation exposure to lead oxide nanoparticles
Introduction. Current data indicate that lead oxide nanoparticles have a more pronounced toxicity compared to microparticles, organic and inorganic lead salts. Lead intoxication is a significant risk factor for the development of cardiovascular diseases. The features of the cardiotoxic effect of lead oxide nanoparticles require further study.The study aims to evaluate changes in clinical, functional, and metabolic parameters characterizing the state of the cardiovascular system during inhalation exposure to lead oxide nanoparticles for 4 months.Materials and methods. The authors conducted an experiment on female rats divided into two equal groups: the main group (n=10) and the control group (n=10). The experimental group was exposed to lead oxide nanoparticles by inhalation at a concentration of 0.2 mg/m³ for 4 months. An electrocardiogram and blood pressure were recorded. Histological examination and metabolomic analysis of heart tissue were performed. The concentration of coproporphyrin and delta-aminolevulinic acid in urine was determined.Results. The scientists found an increase in pulse pressure (p=0.020), a reduction in the QT interval in the first lead (p=0.027) and the QRS complex in the second (p=0.020). There was an increase in the size of cardiomyocytes (p<0.001). Metabolic analysis of heart tissue revealed an increase in the levels of proline (p=0.019), adenine (p=0.010), methionine sulfoxide (p=0.038), succinyl adenosine (p=0.019), linoleic acid (p=0.010), lysophosphatidylethanolamines 18:0 and 18:1 (p=0.010 and p=0.038, respectively) and lysophosphatidylcholines 18:1 and 18:2 (p=0.038 and p=0.038).Limitations. This work does not take into account possible intersex and interspecific differences.Conclusion. The results of the study showed that exposure to lead oxide nanoparticles causes changes in blood pressure, has a proarrhythmogenic effect, contributes to an increase in the size of cardiomyocytes and the development of oxidative stress.Ethics. The study was approved at a meeting of the Local Ethics Committee of the Yekaterinburg Medical Scientific Center for the Prevention and Health Protection of Industrial Workers of Rospotrebnadzor (Protocol No. 4 dated 07/12/2022).Contributions:Minigalieva I.A. — concept and design of research, writing, editing;Sutunkova M.P. — concept and design of research, editing;Kopenkin M.A. — data collection and processing, text writing, editing;Unesikhina M.C. — data collection and processing, text writing, editing;Petrunina E.M. — data collection and processing;Bazarnyi V.V. — concept and design of research, editing;All co-authors — approving the final version of the article and ensuring the integrity of all parts of the article.Funding. The study had no funding.Conflict of interest. The authors declare no conflict of interest.Received: 07.05.2026 / Accepted: 14.05.2026 / Published: 11.08.2026
- Open Access
- 2 July 2026
- Published by Ural State Medical University in Ural Medical Journal
- Vol. 25 (3) , 23-33
The Diagnostic Value of Certain Immunoactive Peptides in Oral Diseases
The Diagnostic Value of Certain Immunoactive Peptides in Oral Diseases | Kopenkin | Ural Medical Journal Клинико-диагностическая ценность некоторых иммуноактивных пептидов при заболеваниях полости рта | Копенкин | Уральский медицинский журнал
- 2 July 2026
- Published by Ural State Medical University in Ural Medical Journal
- Vol. 25 (3) , 23-33
Open AccessThe Diagnostic Value of Certain Immunoactive Peptides in Oral Diseases
The Diagnostic Value of Certain Immunoactive Peptides in Oral Diseases | Kopenkin | Ural Medical Journal Клинико-диагностическая ценность некоторых иммуноактивных пептидов при заболеваниях полости рта | Копенкин | Уральский медицинский журнал
- Open Access
- 26 April 2026
- Published by Ural State Medical University in Ural Medical Journal
- Vol. 25 (2) , 31-45
Clinical and Laboratory Study of a New Immunomodulatory Mouthwash in Inflammatory Periodontal Diseases in Elderly Patients
Relevance . Elderly patients have a change in immune status. Manifestations of senescent immunodeficiency are present in the oral cavity, aggravate the main dental diseases. Local immunity plays a key role in the effective treatment and prevention of inflammatory diseases in the oral cavity. Materials and methods . A new immunomodulatory mouthwash has been developed based on the “Immunokol LP”. It is created from bovine colostrum products. A clinical study of the effectiveness of a new mouthwash for inflammatory periodontal diseases in elderly patients included determining hygienic and periodontal indices before and after a course of its use. The laboratory study included an analysis of oral fluid parameters (general parameters, inflammatory reaction, local immunity, mineral metabolism). Results . Clinical evaluation of the effectiveness of the new mouthwash showed an improvement in the hygienic condition of the oral cavity of patients, a decrease in the severity of residual inflammation in the periodontal tissues after a course of its use. Laboratory testing of oral fluid showed a mild anti-inflammatory and immunomodulatory effect of the mouthwash, an increase in calcium concentration, calcium-to-phosphorus ratio. Conclusion . The new immunomodulatory mouthwash helps to reduce inflammation in the oral tissues and maintain remission of inflammatory periodontal diseases in elderly patients.
- 26 April 2026
- Published by Ural State Medical University in Ural Medical Journal
- Vol. 25 (2) , 31-45
Open AccessClinical and Laboratory Study of a New Immunomodulatory Mouthwash in Inflammatory Periodontal Diseases in Elderly Patients
Relevance . Elderly patients have a change in immune status. Manifestations of senescent immunodeficiency are present in the oral cavity, aggravate the main dental diseases. Local immunity plays a key role in the effective treatment and prevention of inflammatory diseases in the oral cavity. Materials and methods . A new immunomodulatory mouthwash has been developed based on the “Immunokol LP”. It is created from bovine colostrum products. A clinical study of the effectiveness of a new mouthwash for inflammatory periodontal diseases in elderly patients included determining hygienic and periodontal indices before and after a course of its use. The laboratory study included an analysis of oral fluid parameters (general parameters, inflammatory reaction, local immunity, mineral metabolism). Results . Clinical evaluation of the effectiveness of the new mouthwash showed an improvement in the hygienic condition of the oral cavity of patients, a decrease in the severity of residual inflammation in the periodontal tissues after a course of its use. Laboratory testing of oral fluid showed a mild anti-inflammatory and immunomodulatory effect of the mouthwash, an increase in calcium concentration, calcium-to-phosphorus ratio. Conclusion . The new immunomodulatory mouthwash helps to reduce inflammation in the oral tissues and maintain remission of inflammatory periodontal diseases in elderly patients.
- 31 July 2025
- Published by Bionika Media in Akusherstvo i ginekologiia
- Vol. 7_2025, 112-120
Study of inflammatory and angiogenic biomarker levels in various biological fluids in women with extragenital endometriosis
- 31 July 2025
- Published by Bionika Media in Akusherstvo i ginekologiia
- Vol. 7_2025, 112-120
Study of inflammatory and angiogenic biomarker levels in various biological fluids in women with extragenital endometriosis
- Open Access
- 6 March 2025
- Published by IRBIS in Obstetrics, Gynecology and Reproduction
- Vol. 19 (1) , 26-34
Clinical and functional significance of determining biological age in women during the reproductive period
Introduction. Biological age (BA) reflects the characteristics of the morphological and physiological state of the human body at a specific period of its life.This concept is of particular importance in reproductive medicine, because actual age does not always correlate with the state of organs and systems.Aim: to develop a method for calculating BA for women aged 20–45 years, considering their physiological state and reproductive function.Materials and Methods. A single-stage non-randomized cohort study was conducted. To create the BA calculation model, a study was conducted with 100 healthy women aged 20–45 years. Seventy-eight parameters were analyzed, including anamnesis data, anthropometric parameters, data of general blood test, biochemical blood test, instrumental studies, assessment of overall antioxidant status (ОAS), from which the most informative variables were selected. The model was developed using multiple linear regression.Results. The most informative indicators for calculating BA were: ОAS, static balance time (SBT), body mass index (BMI), and number of former pregnancies. The developed BA calculation formula demonstrated high accuracy, correlating with chronological age (correlation coefficient of 0.947).Conclusion. The proposed BA calculation method is specifically designed for women of reproductive age and shows high accuracy and correlation with chronological age. The inclusion of antioxidant protection parameters, functional state indicators, and reproductive history makes the method versatile and applicable not only in reproductive medicine but also in general medical practice, obstetrics, gynecology, and other fields.
- 6 March 2025
- Published by IRBIS in Obstetrics, Gynecology and Reproduction
- Vol. 19 (1) , 26-34
Open AccessClinical and functional significance of determining biological age in women during the reproductive period
Introduction. Biological age (BA) reflects the characteristics of the morphological and physiological state of the human body at a specific period of its life.This concept is of particular importance in reproductive medicine, because actual age does not always correlate with the state of organs and systems.Aim: to develop a method for calculating BA for women aged 20–45 years, considering their physiological state and reproductive function.Materials and Methods. A single-stage non-randomized cohort study was conducted. To create the BA calculation model, a study was conducted with 100 healthy women aged 20–45 years. Seventy-eight parameters were analyzed, including anamnesis data, anthropometric parameters, data of general blood test, biochemical blood test, instrumental studies, assessment of overall antioxidant status (ОAS), from which the most informative variables were selected. The model was developed using multiple linear regression.Results. The most informative indicators for calculating BA were: ОAS, static balance time (SBT), body mass index (BMI), and number of former pregnancies. The developed BA calculation formula demonstrated high accuracy, correlating with chronological age (correlation coefficient of 0.947).Conclusion. The proposed BA calculation method is specifically designed for women of reproductive age and shows high accuracy and correlation with chronological age. The inclusion of antioxidant protection parameters, functional state indicators, and reproductive history makes the method versatile and applicable not only in reproductive medicine but also in general medical practice, obstetrics, gynecology, and other fields.
- 30 November 2024
- Published by OOO "Opponent" in Медицинский оппонент
- Vol. 27 (3(27)) , 10-15
Диагностические и прогностические цитокиновые маркеры винкристиновой полиневропатии у детей с острым лимфобластным лейкозом. Ковтун О.П., Корякина О.В., Базарный В.В.
Цель исследования заключалась в определении цитокинов плазмы крови и ликвора, претендующих на роль потенциальных диагностических и прогностических маркеров винкристиновой полиневропатии у детей с острым лимфобластным лейкозом. На основании полученных результатов установлены изменения содержания плазменных и ликворных цитокинов в группе пациентов с винкристиновой полиневропатией, что свидетельствует об их связи с развитием данного нейротоксического расстройства. Для совершенствования комплекса обследования детей с винкристиновой полиневропатией разработана диагностическая панель с оптимальным набором цитокинов.
- 30 November 2024
- Published by OOO "Opponent" in Медицинский оппонент
- Vol. 27 (3(27)) , 10-15
Диагностические и прогностические цитокиновые маркеры винкристиновой полиневропатии у детей с острым лимфобластным лейкозом. Ковтун О.П., Корякина О.В., Базарный В.В.
Цель исследования заключалась в определении цитокинов плазмы крови и ликвора, претендующих на роль потенциальных диагностических и прогностических маркеров винкристиновой полиневропатии у детей с острым лимфобластным лейкозом. На основании полученных результатов установлены изменения содержания плазменных и ликворных цитокинов в группе пациентов с винкристиновой полиневропатией, что свидетельствует об их связи с развитием данного нейротоксического расстройства. Для совершенствования комплекса обследования детей с винкристиновой полиневропатией разработана диагностическая панель с оптимальным набором цитокинов.
- Open Access
- 15 August 2024
- Published by Paediatrician Publishers LLC in Annals of the Russian academy of medical sciences
- Vol. 79 (3) , 216-222
Clinical Value of Stromal Cell Factor (Sdf-1) Determination in Chemotherapy-Induced Peripheral Polyneuropathy in Patients with Hematological Malignancies (Results of a Prospective Cohort Study)
Background. Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most common complications of chemotherapy for hemoblastoses in children, which, according to researchers, occurs in 30–100% of patients in the treatment of acute lymphoblastic leukemia (ALL). Reliable laboratory markers of this disease have not been established, while their use would be appropriate in patient monitoring. Aims — to establish the clinical value of determining the stromal cell factor (SDF-1, CXCL12) in the laboratory monitoring of chemotherapy-induced polyneuropathy in the treatment of ALL in children. Methods. A single-center prospective cohort non-randomized study was conducted in the period from 2019 to 2022 of patients with ALL treated with vincristine as the main treatment. Some of them developed vincristine-induced peripheral polyneuropathy as a variant of CIPN during treatment. On this basis, all patients were divided into two groups — with CIPN (main) and without peripheral polyneuropathy (comparison group). A clinical neurophysiological study was performed, as well as the determination of stromal cell factor (SDF- 1, CXCL12) in the plasma and cerebrospinal fluid (CSF) of patients at different stages of therapy. Results. In the blood plasma of children with CIPN, the content of SDF-1 did not differ from the of healthy children and the comparison group, and during chemotherapy there was a tendency to decrease its level. In the CSF of patients of the main group the concentration of SDF-1 increased at the end of induction. The clinical value of this parameter was determined, with its content in the CSF 410 pg/ml AUC = 0.75; OR = 2.200. Conclusion. One of the candidates for the role of a laboratory marker of chemotherapy-induced peripheral polyneuropathy is the chemokine SDF-1, the concentration of which in the CSF increased in patients with ALL. In this study, the clinical value of this parameter has been established, on the basis of which it can be concluded that this laboratory parameter allows the diagnosis of CIPN with moderate accuracy, and the joint determination of this factor in blood and liquor slightly increases the accuracy of diagnosis.
- 15 August 2024
- Published by Paediatrician Publishers LLC in Annals of the Russian academy of medical sciences
- Vol. 79 (3) , 216-222
Open AccessClinical Value of Stromal Cell Factor (Sdf-1) Determination in Chemotherapy-Induced Peripheral Polyneuropathy in Patients with Hematological Malignancies (Results of a Prospective Cohort Study)
Background. Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most common complications of chemotherapy for hemoblastoses in children, which, according to researchers, occurs in 30–100% of patients in the treatment of acute lymphoblastic leukemia (ALL). Reliable laboratory markers of this disease have not been established, while their use would be appropriate in patient monitoring. Aims — to establish the clinical value of determining the stromal cell factor (SDF-1, CXCL12) in the laboratory monitoring of chemotherapy-induced polyneuropathy in the treatment of ALL in children. Methods. A single-center prospective cohort non-randomized study was conducted in the period from 2019 to 2022 of patients with ALL treated with vincristine as the main treatment. Some of them developed vincristine-induced peripheral polyneuropathy as a variant of CIPN during treatment. On this basis, all patients were divided into two groups — with CIPN (main) and without peripheral polyneuropathy (comparison group). A clinical neurophysiological study was performed, as well as the determination of stromal cell factor (SDF- 1, CXCL12) in the plasma and cerebrospinal fluid (CSF) of patients at different stages of therapy. Results. In the blood plasma of children with CIPN, the content of SDF-1 did not differ from the of healthy children and the comparison group, and during chemotherapy there was a tendency to decrease its level. In the CSF of patients of the main group the concentration of SDF-1 increased at the end of induction. The clinical value of this parameter was determined, with its content in the CSF 410 pg/ml AUC = 0.75; OR = 2.200. Conclusion. One of the candidates for the role of a laboratory marker of chemotherapy-induced peripheral polyneuropathy is the chemokine SDF-1, the concentration of which in the CSF increased in patients with ALL. In this study, the clinical value of this parameter has been established, on the basis of which it can be concluded that this laboratory parameter allows the diagnosis of CIPN with moderate accuracy, and the joint determination of this factor in blood and liquor slightly increases the accuracy of diagnosis.
- Open Access
- 11 July 2024
- Published by Ural State Medical University in Ural Medical Journal
- Vol. 23 (3) , 46-58
Mixed Saliva Chemical Parameters Changes in Age‑Related Oral Diseases
Introduction. The prevalence of oral cavity age-related diseases, such as chronic periodontitis (CP) and oral lichen planus (OLP) increases in the elderly and senile age people. The aim of the study was to evaluate changes in the biochemical parameters of mixed saliva in age-related oral diseases and evaluate impact of correction by total protein concentration.Materials and methods. The study included 86 elderly people from 60 to 74 years. They were divided into following groups: excessive attrition of teeth patients (n = 16); moderate CP patients (n = 22); OLP patients (n = 28); healthy peoples (n = 20). Reagent strips Siemens Multistix 10 SG (USA), analyzer Siemens Clinitek Status+ (USA), chemistry analyzer Mindray BS-240Pro (China) were used. In total, 16 biochemical markers and 4 calculated indices were determined. Saliva results were expressed without any correction, and corrected by total protein concentration.Results. It was found that OLP patients differed by a higher specific gravity and an increased level of total protein and calcium from the control group. CP patients had a higher level of c-reactive protein in compared to the healthy peoples. There were no differences between groups after correction.Discussion. The data corresponded to literature sources describing mixed saliva changes in age-related oral diseases. However, correction methods practically were not used in the considered works.Conclusion. Mixed saliva chemical markers changed in age-related oral diseases. It is necessary to find the optimal correction method because dilution and viscosity can significantly affect mixed saliva research results.
- 11 July 2024
- Published by Ural State Medical University in Ural Medical Journal
- Vol. 23 (3) , 46-58
Open AccessMixed Saliva Chemical Parameters Changes in Age‑Related Oral Diseases
Introduction. The prevalence of oral cavity age-related diseases, such as chronic periodontitis (CP) and oral lichen planus (OLP) increases in the elderly and senile age people. The aim of the study was to evaluate changes in the biochemical parameters of mixed saliva in age-related oral diseases and evaluate impact of correction by total protein concentration.Materials and methods. The study included 86 elderly people from 60 to 74 years. They were divided into following groups: excessive attrition of teeth patients (n = 16); moderate CP patients (n = 22); OLP patients (n = 28); healthy peoples (n = 20). Reagent strips Siemens Multistix 10 SG (USA), analyzer Siemens Clinitek Status+ (USA), chemistry analyzer Mindray BS-240Pro (China) were used. In total, 16 biochemical markers and 4 calculated indices were determined. Saliva results were expressed without any correction, and corrected by total protein concentration.Results. It was found that OLP patients differed by a higher specific gravity and an increased level of total protein and calcium from the control group. CP patients had a higher level of c-reactive protein in compared to the healthy peoples. There were no differences between groups after correction.Discussion. The data corresponded to literature sources describing mixed saliva changes in age-related oral diseases. However, correction methods practically were not used in the considered works.Conclusion. Mixed saliva chemical markers changed in age-related oral diseases. It is necessary to find the optimal correction method because dilution and viscosity can significantly affect mixed saliva research results.
- Open Access
- 18 May 2024
- Published by Pacific State Medical University in Pacific Medical Journal
- No. 1,p. 35-38
Neurotrophins and vascular endothelial growth factor in oral fluid of elderly patients: diagnostic value for chronic periodontitis and oral lichen planus
Objective. To evaluate the vascular endothelial growth factor A and brain-derived neurotrophic factor in the oral fluid of mature and elderly patients with chronic periodontitis and oral lichen planus. Materials and methods. The study involved 56 participants. The control group consisted of healthy volunteers aged 18–44 (n=10). The comparison group included relatively healthy elderly people aged 60–74 (n=12). The distinguished groups of patients with age-associated dental diseases included: moderate chronic periodontitis mature patients of 45–59 years (n=10) and elderly patients (n=14), as well as elderly patients with oral lichen planus (n=10). The patients underwent dental examination. The content of neurotrophins and vascular endothelial growth factor A in saliva (BDNF/ NGF beta/ VEGF-A Human ProcartaPlex Simplex Kit, Invitrogen, USA) was determined by the multiparametric fluorescence analysis with magnetic microspheres (xMAP, Luminex 200, USA) in compliance with the manufacturer protocol. Results. The groups reveal no differences in the level of brain-derived neurotrophic factor and nerve growth factor beta. The elderly patients with oral lichen planus were found to obtain the highest angiogenesis factor, which diagnostic value was assessed by ROC-analysis. The test appears moderately accurate (AUC=0.875). Conclusion. Vascular endothelial growth factor A can be considered for laboratory monitoring of elderly patients with oral lichen planus.
- 18 May 2024
- Published by Pacific State Medical University in Pacific Medical Journal
- No. 1,p. 35-38
Open AccessNeurotrophins and vascular endothelial growth factor in oral fluid of elderly patients: diagnostic value for chronic periodontitis and oral lichen planus
Objective. To evaluate the vascular endothelial growth factor A and brain-derived neurotrophic factor in the oral fluid of mature and elderly patients with chronic periodontitis and oral lichen planus. Materials and methods. The study involved 56 participants. The control group consisted of healthy volunteers aged 18–44 (n=10). The comparison group included relatively healthy elderly people aged 60–74 (n=12). The distinguished groups of patients with age-associated dental diseases included: moderate chronic periodontitis mature patients of 45–59 years (n=10) and elderly patients (n=14), as well as elderly patients with oral lichen planus (n=10). The patients underwent dental examination. The content of neurotrophins and vascular endothelial growth factor A in saliva (BDNF/ NGF beta/ VEGF-A Human ProcartaPlex Simplex Kit, Invitrogen, USA) was determined by the multiparametric fluorescence analysis with magnetic microspheres (xMAP, Luminex 200, USA) in compliance with the manufacturer protocol. Results. The groups reveal no differences in the level of brain-derived neurotrophic factor and nerve growth factor beta. The elderly patients with oral lichen planus were found to obtain the highest angiogenesis factor, which diagnostic value was assessed by ROC-analysis. The test appears moderately accurate (AUC=0.875). Conclusion. Vascular endothelial growth factor A can be considered for laboratory monitoring of elderly patients with oral lichen planus.
- Open Access
- 6 March 2024
- Published by Ural State Medical University in Ural Medical Journal
- Vol. 23 (1) , 46-59
Markers of Collagen Degradation in Remodeling and Diastolic Dysfunction of Left Ventricle in Patients with Arterial Hypertension
Introduction. Myocardial remodeling is a consequence or predictor of several cardiovascular diseases. The key process in myocardial remodeling is the degradation of collagen fibers, mediated by the activity of matrix metalloproteinases and their tissue inhibitor.The aim of this study was to evaluate serum levels of matrix metalloproteinase type 9 and tissue inhibitor of matrix metalloproteinase type 1 in female patients with arterial hypertension, myocardial remodeling, and diastolic dysfunction.Materials and methods. A cross-sectional study that included 84 postmenopausal women. All patients underwent echocardiography. Left ventricular remodeling was assessed according to Ganau classification, and diastolic function was evaluated using transmittal flow parameters. Serum analysis included the determination of MMP-9 and TIMP-1 levels using an enzyme-linked immunosorbent assay.Results. The median concentration of MMP-9 in the sample was 2 295.00 (923.60–4 114.00) ng/ml, TIMP — 1–17 010.00 (16 780.00–17 170.00) ng/ml. When evaluating the echocardiographic parameters of the patients included in the study, changes were revealed that indicate structural and functional remodeling of the LV and DD. 29 patients (35 %) had normal geometry, 6 patients (7 %) had concentric myocardial remodeling, 21 patients (25 %) had concentric myocardial hypertrophy, 28 cases (33 %) had eccentric myocardial hypertrophy. Statistically significant changes in the activity of MMP-9 and TIMP-1 were revealed in patients with various structural and geometric variants of remodeling. DD was detected in all patients included in the study: I degree was detected in 25 patients (30 %), II degree was determined in 59 cases (70 %). Using one-way analysis of variance, statistically significant differences in the level of MMP-9 in patients with grades I and II DD were determined. MMP-9 and MMP-9/TIMP-1 in patients with grade II DD are significantly higher than in patients with grade I.Discussion. Under pathophysiological conditions, the proteolytic properties of MMP-9 contribute to the stimulation of the immune response, initiating pathogenesis and aggravating the progression of the disease. Evaluation of the activity of MMP-9 and TIMP-1 in patients with arterial hypertension may be a marker of myocardial remodeling.Conclusion. An increase in the activity of matrix metalloproteinase type 9 and a decrease in the activity of a tissue inhibitor of matrix metalloproteinases type 1 were revealed in patients with arterial hypertension, myocardial remodeling and LV diastolic dysfunction. The level of MMP-9 is associated with the degree of diastolic dysfunction and the structural-geometric type of LV remodeling.
- 6 March 2024
- Published by Ural State Medical University in Ural Medical Journal
- Vol. 23 (1) , 46-59
Open AccessMarkers of Collagen Degradation in Remodeling and Diastolic Dysfunction of Left Ventricle in Patients with Arterial Hypertension
Introduction. Myocardial remodeling is a consequence or predictor of several cardiovascular diseases. The key process in myocardial remodeling is the degradation of collagen fibers, mediated by the activity of matrix metalloproteinases and their tissue inhibitor.The aim of this study was to evaluate serum levels of matrix metalloproteinase type 9 and tissue inhibitor of matrix metalloproteinase type 1 in female patients with arterial hypertension, myocardial remodeling, and diastolic dysfunction.Materials and methods. A cross-sectional study that included 84 postmenopausal women. All patients underwent echocardiography. Left ventricular remodeling was assessed according to Ganau classification, and diastolic function was evaluated using transmittal flow parameters. Serum analysis included the determination of MMP-9 and TIMP-1 levels using an enzyme-linked immunosorbent assay.Results. The median concentration of MMP-9 in the sample was 2 295.00 (923.60–4 114.00) ng/ml, TIMP — 1–17 010.00 (16 780.00–17 170.00) ng/ml. When evaluating the echocardiographic parameters of the patients included in the study, changes were revealed that indicate structural and functional remodeling of the LV and DD. 29 patients (35 %) had normal geometry, 6 patients (7 %) had concentric myocardial remodeling, 21 patients (25 %) had concentric myocardial hypertrophy, 28 cases (33 %) had eccentric myocardial hypertrophy. Statistically significant changes in the activity of MMP-9 and TIMP-1 were revealed in patients with various structural and geometric variants of remodeling. DD was detected in all patients included in the study: I degree was detected in 25 patients (30 %), II degree was determined in 59 cases (70 %). Using one-way analysis of variance, statistically significant differences in the level of MMP-9 in patients with grades I and II DD were determined. MMP-9 and MMP-9/TIMP-1 in patients with grade II DD are significantly higher than in patients with grade I.Discussion. Under pathophysiological conditions, the proteolytic properties of MMP-9 contribute to the stimulation of the immune response, initiating pathogenesis and aggravating the progression of the disease. Evaluation of the activity of MMP-9 and TIMP-1 in patients with arterial hypertension may be a marker of myocardial remodeling.Conclusion. An increase in the activity of matrix metalloproteinase type 9 and a decrease in the activity of a tissue inhibitor of matrix metalloproteinases type 1 were revealed in patients with arterial hypertension, myocardial remodeling and LV diastolic dysfunction. The level of MMP-9 is associated with the degree of diastolic dysfunction and the structural-geometric type of LV remodeling.